Salva Health Wins TechCrunch Disrupt 2024 Startup Battlefield 200 With Portable Breast Cancer Device

TechCrunch selected 200 of the most promising startups from thousands of applications for its 2024 Startup Battlefield 200 competition, with Salva Health taking the top prize for its portable, AI-powered breast cancer detection technology aimed at underserved markets in Latin America. At TechCrunch Disrupt 2024, Salva Health claimed the $100,000 equity-free prize and the Disrupt Cup for its innovative approach to addressing critical healthcare disparities. Founded by Valentina Agudelo and two co-founders, the company developed a portable device that enables early breast cancer screening in regions where traditional diagnostic equipment like mammograms remains inaccessible, particularly in rural areas across Latin America.